Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725783) titled 'Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma' on July 21.

Study Type: Observational [Patient Registry]

Primary Sponsor: Peking University People's Hospital

Condition: Ewing Sarcoma

Recruitment Status: Recruiting

Date of First Enrollment: September 1, 2025

Target Sample Size: 100

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07725783

Published by HT Digital Content Services with permission from Health Daily Digest....